Really nice results from transgenes' mature data on Phase IIb clinical trials using Virax' co-X-gene tech. Mature data shows the primary endpoint of progression-free survival (PFS) was met and the overall survival data suggests a clinically meaningful improvement.
Great news for the patients (in the experimental treatment group, at least), Transgene and hopefully Virax. Fingers crossed this lures a new partner for Transgene to progress to Phase III trials.
http://online.wsj.com/article/PR-CO-20140527-908891.html
transgene news, page-4
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
